Skip to main content
Applied and Environmental Microbiology logoLink to Applied and Environmental Microbiology
. 2018 Aug 31;84(18):e01186-18. doi: 10.1128/AEM.01186-18

Bacterial Endospores as Phage Genome Carriers and Protective Shells

Naiana Gabiatti a,b, Pingfeng Yu a,, Jacques Mathieu a, Grant W Lu c, Xifan Wang a, Hangjun Zhang d, Hugo M Soares b, Pedro J J Alvarez a
Editor: Janet L Schottele
PMCID: PMC6121981  PMID: 30006404

Bacteriophages are being considered for the control of multidrug-resistant and other problematic bacteria in environmental systems. However, the efficacy of phage-based microbial control is limited by infectivity loss during phage delivery and/or storage. Here, we exploit the pseudolysogenic state of phages, which involves incorporation of their genome into bacterial endospores (without integration into the host chromosome), to enhance survival in unfavorable environments. We isolated polyvalent (broad-host-range) phages that efficiently infect both benign and opportunistically pathogenic Bacillus strains and encapsulated the phage genomes in B. subtilis endospores to significantly improve resistance to various environmental stressors. Encapsulation by spores also significantly enhanced phage genome viability during storage. We also show that endospore germination can be induced on demand with nutrient germinants that trigger the release of active phages. Overall, we demonstrate that encapsulation of polyvalent phage genomes into benign endospores holds great promise for broadening the scope and efficacy of phage biocontrol.

KEYWORDS: endospore, bacteriophage, stressors, phage protection, Bacillus cereus, microbial control

ABSTRACT

Bacterial endospores can serve as phage genome protection shells against various environmental stresses to enhance microbial control applications. The genomes of polyvalent lytic Bacillus phages PBSC1 and PBSC2, which infect both B. subtilis subsp. subtilis and B. cereus NRS 248, were incorporated into B. subtilis endospores (without integration into the host chromosome). When PBSC1 and PBSC2 were released from germinating endospores, they significantly inhibited the growth of the targeted opportunistic pathogen B. cereus. Optimal endospore entrapment was achieved when phages were introduced to the fast-sporulating prespores at a multiplicity of infection of 1. Longer endospore maturation (48 h versus 24 h) increased both spore yield and efficiency of entrapment. Compared with free phages, spore-protected phage genomes showed significantly higher resistance toward high temperatures (60 to 80°C), extreme pH (pH 2 or pH 12), and copper ions (0.1 to 10 mg/liter). Endospore germination is inducible by low concentrations of l-alanine or by a germinant mixture (l-asparagine, d-glucose, d-fructose, and K+) to trigger the expression, assembly, and consequent release of phage particles within 60 to 90 min. Overall, the superior resiliency of polyvalent phages protected by endospores might enable nonrefrigerated phage storage and enhance phage applications after exposure to adverse environmental conditions.

IMPORTANCE Bacteriophages are being considered for the control of multidrug-resistant and other problematic bacteria in environmental systems. However, the efficacy of phage-based microbial control is limited by infectivity loss during phage delivery and/or storage. Here, we exploit the pseudolysogenic state of phages, which involves incorporation of their genome into bacterial endospores (without integration into the host chromosome), to enhance survival in unfavorable environments. We isolated polyvalent (broad-host-range) phages that efficiently infect both benign and opportunistically pathogenic Bacillus strains and encapsulated the phage genomes in B. subtilis endospores to significantly improve resistance to various environmental stressors. Encapsulation by spores also significantly enhanced phage genome viability during storage. We also show that endospore germination can be induced on demand with nutrient germinants that trigger the release of active phages. Overall, we demonstrate that encapsulation of polyvalent phage genomes into benign endospores holds great promise for broadening the scope and efficacy of phage biocontrol.

INTRODUCTION

Bacteriophages are garnering significant interest as self-replicating antibacterial agents in the face of the widespread and accelerating onset of multidrug-resistant bacteria and other bacterial control challenges (e.g., biofouling and microbe-induced corrosion) (13). Phages offer numerous advantages over conventional antimicrobial agents, such as self-propagation in the presence of suitable hosts and lower potential environmental impact due to host specificity, resulting in minimal off-target kills (4). The use of phages for microbial control has recently expanded from traditional medical applications to food safety, water and wastewater treatment, and beyond (57). However, phage-based biocontrol (i.e., killing of problematic target bacteria) can be hindered by infectivity loss (8). Specifically, adverse environmental conditions (e.g., high temperature [50°C], high copper ion concentration [300 mg/liter], and acidic conditions [pH 2]) during phage delivery could irreversibly damage the phage genome or proteins involved in host recognition within minutes (9, 10). Moreover, phage neutralization by antibodies or other compounds also hinders their infectivity (11, 12). Therefore, microencapsulation has been proposed to protect therapeutic phages (13). For example, an alginate/CaCO3 encapsulation method was used to protect Salmonella and Staphylococcus phages during transit through the acidic gastrointestinal tract (14, 15). Nevertheless, alginate gel encapsulation can only improve phage resistance to low pH, and the literature is scarce on phage protection during delivery through other adverse conditions (e.g., high temperature) or during long-term storage, which underscores an opportunity for novel strategies that enhance phage survival and application of phages for microbial control.

Bacterial endospores are metabolically dormant and resilient toward various environmental stressors (16), and they can be induced to germinate within minutes upon exposure to germinants, such as l-alanine and l-valine for Bacillus subtilis (17). Therefore, endospores could be used as protective shells and delivery vectors for phage genomes that enter into a carrier state, known as pseudolysogeny (18). This is a state of stalled phage development within a host cell, without either phage genome replication or phage genome integration into the host chromosome (19). Pseudolysogeny occurs most frequently under nutrient-deprived conditions, when host DNA replication and protein synthesis stop (20). For example, the genomes of some Bacillus phages (e.g., φ29 and φe) can be incorporated into developing endospores (21, 22). Accordingly, the endospore-protected phage genomes exhibit dramatically improved resistance to common environmental stressors (23). Upon endospore germination, the phage continues its lytic life cycle, leading to cell lysis and phage release (18). However, no previous studies have considered the use of endospores to enhance phage applications by increasing their tolerance to environmental stressors and their viability after long-term storage.

One major hurdle in using spores as phage carriers and protective shells is the narrow host range of most known phages, which precludes infecting both benign spore-forming hosts and target bacteria. However, phage polyvalence (i.e., broad host range) would facilitate their encapsulation by benign bacterial endospores for subsequent targeting of problematic bacteria. Recent studies suggest that polyvalent phages are more widespread than previously recognized (24, 25) and can be preferentially isolated by using sequential hosts (26). Advances in molecular biology and synthetic biology may also be used to extend and tune phage host range (27, 28).

Here, polyvalent phages PBSC1 and PBSC2, which infect both B. subtilis and Bacillus cereus, were isolated from soil. B. subtilis was chosen as the production host because of its safety (29). B. cereus was used as a model pathogen for food spoilage and foodborne disease (30). PBSC1 and PBSC2 genomes were incorporated into B. subtilis endospores, and sporulation time, multiplicity of infection, and maturation time were optimized to achieve a high efficiency of phage genome entrapment. Phage genome activity was preserved when the endospores were exposed to adverse conditions (e.g., high temperature of 80°C, extreme pHs of 2 and 12, and 10 mg/liter of copper ions) or long-term unrefrigerated storage. We also show on-command phage release from germinated spores (and effective control of target bacteria) when the spores are induced with common germinants. Accordingly, we propose a novel approach to enhance and broaden phage-based microbial control applications (Fig. 1).

FIG 1.

FIG 1

Strategy for phage genome entrapment in spores, protection, and subsequent progeny release. Development of bacterial spores as phage carriers and protective shells by taking advantage of the pseudolysogenic state to enhance both phage resistance against environmental stressors and phage viability after long-term storage. Only phage genomes that enter the prespore component may become successfully entrapped into the mature spores.

RESULTS AND DISCUSSION

Polyvalent phage isolation and characterization.

Soil samples were used for polyvalent Bacillus phage isolation because Bacillus species commonly inhabit soils and phages usually coexist with their hosts (31). With a sequential multiple-host approach, two polyvalent phages (PBSC1 and PBSC2) were isolated based on their ability to infect both B. subtilis subsp. subtilis and B. cereus NRS 248 cells with a high efficiency of plating (EOP > 0.7; n = 6) (Table 1). The electron microscopic images (n = 10) showed that PBSC1, with a head of 80 ± 3 nm and a long tail of 70 ± 2 nm, belonged to the family Myoviridae, while PBSC2, with a head of 70 ± 1 nm and a barely visible tail, belonged to the family Podoviridae (Fig. 2).

TABLE 1.

EOPa and life cycle parameters of phages PBSC1 and PBSC2 toward their hosts

Phage Host EOP Adsorption rate constant (10−10 ml/min) Latent time (min) Burst size (PFU/cell ± SD)
PBSC1 B. subtilis subsp. subtilis 1.00 17.2 ± 0.7 35 132 ± 15
B. cereus NRS 248 0.74 6.59 ± 0.8 35 101 ± 14
PBSC2 B. subtilis subsp. subtilis 1.00 5.35 ± 0.4 40 99 ± 12
B. cereus NRS 248 0.76 4.32 ± 0.5 40 86 ± 12
a

Efficiency of plating (EOP) was quantified by calculating the ratio of phage plaque titers obtained with a given host to the phage plaque titers obtained with B. subtilis.

FIG 2.

FIG 2

Growth patterns and morphology of polyvalent phages PBSC1 and PBSC2. One-step growth curves of (A) PBSC1 and (B) PBSC2, infecting both B. subtilis and B. cereus. Error bars in all figures indicate standard deviations from the mean of triplicate independent experiments. The electron microscopic images revealed that phages PBSC1 and PBSC2 belonged to the families of Myoviridae and Podoviridae, respectively. Bar, 50 nm.

Phage PBSC1 displayed greater affinity to B. subtilis relative to B. cereus, with adsorption rate constants of 1.7 × 10−9 ml/min for B. subtilis and 6.6 ×10−10 ml/min for B. cereus. Phage PBSC2 showed lower values of 5.4 ×10−10 and 4.3 ×10−10 ml/min for B. subtilis and B. cereus, respectively (Table 1 and Fig. S1 in the supplemental material). The latent periods of PBSC1 and PBSC2 in B. subtilis were 35 min and 40 min, respectively, and burst sizes were 132 and 99 PFU/cell, respectively (Fig. 2 and Table 1), which indicates that B. subtilis can serve as production hosts for both phages. Both PBSC1 and PBSC2 significantly inhibit the growth of B. cereus (Fig. 3A2 and 3B2). However, due to the development of phage-resistant mutants (Fig. 3A2 and 3B2), it may be necessary to consider phage cocktails or combining phage biocontrol with other antimicrobial agents to ensure successful application (32, 33).

FIG 3.

FIG 3

Batch growth experiments showing the inhibitory effects of PBSC1 and PBSC2 on the hosts. The inhibitory effects of free PBSC1 and spore-released PBSC1 (S-PBSC1) on B. subtilis (A1) and B. cereus (A2). The inhibitory effects of free PBSC2 and spore-released PBSC2 (S-PBSC2) on B. subtilis (B1) and B. cereus (B2). The initial MOI was 10.

Incorporation of phage genomes into bacterial endospores.

To test whether phages PBSC1 and PBSC2 could be incorporated into endospores (in the form of a genome, as shown in Fig. 1) as previously reported for B. subtilis phages (e.g., φ29 and φe) (21, 22), we introduced phage PBSC1 and PBSC2 into sporulating B. subtilis suspensions. Since thermal treatment (70°C for 30 min) ensured the inactivation of unprotected phages, the production of phage plaques when the endospore suspensions were subjected to double-layer agar assays indicates that the phage genomes were incorporated into and protected by the endospores (see Fig. S2 in the supplemental material). Batch growth experiments showed that phages released from the endospores maintained broad host ranges and exhibited similar infective capability to that of their ancestors (Fig. 3). Electron microscopic images showed no changes in phage morphology due to endospore entrapment, and no endogenous prophages of B. subtilis were detected when the spores geminated (see Fig. S3 in the supplemental material).

Sporulation stage and multiplicity of infection (MOI) are crucial factors to achieving high phage genome entrapment.

The fraction of refractile forms of B. subtilis continuously increased in the sporulation medium while phage adsorption rates decreased (Fig. 4A and B), indicating the sporulation of B. subtilis. Although phage PBSC1 had higher entrapment efficiency than PBSC2 under the tested conditions, the two phages showed similar entrapment patterns at the different times tested during the sporulation process (Fig. 4C and D). At MOIs of 1 and 10, the optimal time for phage genome entrapment was approximately 10 h postinoculation, when about 44% of cells were endospores and sporulation was occurring at the highest rates (Fig. 4A). However, at a lower MOI of 0.1, the optimal time was 8 h postinoculation, when about 10% of cells were endospores.

FIG 4.

FIG 4

B. subtilis sporulation time and efficiency of phage incorporation into endospores. (A) The fraction of B. subtilis in refractile forms (e.g., spores) increased with incubation time in sporulation medium. (B) PBSC1 relative adsorption rate during B. subtilis sporulation process. Efficiency of entrapment for phages PBSC1 (C) and PBSC2 (D) at different MOIs and incubation times.

Assuming a Poisson distribution for phage adsorption (34), about 100% of the bacteria would absorb at least one phage at an MOI of 10, compared to 63.2% at an MOI of 1 and 9.5% at an MOI of 0.1. However, higher phage adsorption did not necessarily result in higher phage entrapment. For high MOIs, phage replication may disrupt the sporulation process, mainly due to nutrient release from lysed cells. Late in the sporulation process (stage V, 14 h), we observed a positive correlation between ln(MOI) and entrapment efficiencies (R2 = 0.99 for both phages).

The timing of phage introduction is important for efficient phage genome entrapment. Adding phages either too early (4 or 6 h) or late (14 h) in the sporulation process resulted in low entrapment efficiencies (<12%) regardless of MOIs. Bacteria in the early stage of sporulation are still vulnerable to phage lytic cycle progression, while bacteria in the late stage of sporulation can interrupt phage recognition and infection because of changes in cell morphology and surface receptors (35). Specifically, the mother cell can engulf the prespore during stage III of sporulation, which would prevent phage contact with the prespore. After engulfment, slowing down of the prespore metabolism makes it highly unlikely that the phage would still be able to infect the prespore. Even if the phage genome enters the prespore, it might still be recognized and degraded as a foreign nucleic acid (36).

Lengthening spore maturation time from 24 h to 48 h not only significantly increased the abundance of total spores (infected and uninfected spores) formed by phage-infected B. subtilis cells (Fig. 4A), but also resulted in a significant increase in phage entrapment efficiency (Fig. 4B). Furthermore, suitable spore crops were obtained within 24 h, but doubling this time achieved higher spore purity (see Fig. S4 in the supplemental material) by promoting vegetative cell lysis (37). The spore maturation time is related to wet heat resistance acquisition by the spore (38), and because purification included thermal treatment (70°C for 30 min), longer maturation resulted in a higher yield of viable spores (Fig. 5A). Similarly, when spores were subjected to thermal treatment, phage genomes were more resistant when encapsulated by more mature (48 h) than less mature (24 h) spores, and they exhibited higher efficiency of spore incorporation (Fig. 5B).

FIG 5.

FIG 5

The effect of spore maturation time on the yield of total spores (A) and phage-entrapping spores (B). Bacteria induced for 8, 10, and 12 h were used with a MOI of 1. Panel A shows the percentage of total spores (infected and uninfected spores) formed by phage-infected B. subtilis subsp. subtilis cells relative to the total of spores formed by uninfected cells. Panel B shows the fraction of the total spores that was infected. The asterisks (*) represent significant difference (P < 0.05) between 24 h maturation and 48 h maturation.

Higher environmental stress resistance for polyvalent phage genomes protected in endospores.

Spore-entrapped phage genomes were significantly more resistant than free phages to high temperature, pH extremes, and copper ions. For example, while free PBSC1 and PBSC2 had high inactivation rates after treatment at 50°C (Fig. 6A), entrapped phage genomes retained infectivity even after treatment at 80°C. This is consistent with results of prior studies demonstrating that endospores can resist temperatures over 100°C (39), mainly due to the low water content in the central core and DNA saturation with α/β-type acid-soluble spore proteins (SASP) (40). Entrapped phages also demonstrated resistance to pH extremes, with a maximum decrease in viability of just 25% at pH 2 and pH 12, whereas free phages were dramatically inactivated below pH 4 or above pH 11 (Fig. 6B). Similarly, we observed a significant reduction in toxicity over a wide range of copper concentrations (Fig. 6C), as the low-permeability inner lipid membrane protects the spore core from DNA-damaging chemicals (41). Finally, we observed first-order decay rate coefficient values of 0.20 and 0.22 day−1 for free PBSC1 and PBSC2, respectively, while the air-dried spore-protected phages did not experience a significant loss of viability over 5 weeks (Fig. 6D). We also assessed the relative viability of treated versus untreated spores with and without entrapped phages. No significant differences were observed between normal spores and spores containing phage genomes under the tested conditions (Fig. 7). Overall, these results illustrate the potential for exploiting the pseudolysogenic state of phages and using endospores as phage genome carriers and protective shells during storage (without the need for refrigeration) or delivery through transiently harsh environmental conditions.

FIG 6.

FIG 6

Free PBSC1 and PBSC2 and entrapped phage resistance assays. (A) Phage viability after thermal treatment for 15 min at the stipulated temperatures (no free phages survived 70°C or higher temperature), (B) after 60 min exposure to extreme pH (i.e., pH 2 to pH 12), (C) after exposure to different copper concentrations, and (D) after storage in the dark at room temperature for the stipulated time.

FIG 7.

FIG 7

Resistance of normal spores and phage-infected spores. The spore maturation time was 48 h. The viability of normal spores and phage-infected spores was calculated based on relative CFU and COI (centers of infection) before and after treatment, respectively. The normal spores and phage-infected spores had similar environmental resistance toward high temperature (80°C), low pH (2), Cu2+ (1 ppm), and UVA (1.2 × 10−9 einstein/cm2/s).

Controlled phage release by stimulating spore germination.

Spore germination and outgrowth is characterized by high variability in the behavior of individual cells. This process is generally initiated when one or more germinant receptors (GRs) located in the inner membrane sense their cognate germinant and initiate a series of biophysical events (42). To control spore germination and hence phage release, the process may be induced by incubation with germinants, such as l-valine, l-alanine, and an AGFK mixture (l-asparagine, d-glucose, d-fructose, and K+) (43). Once the spore GRs recognize the proper nutrients, the spore commits to germination and the process continues, even if the germinant is removed or binding is reversed and inhibited (44). Considering the potential formation of superdormant spores of Bacillus, high levels of nutrient germinant mixtures that activate multiple receptors may be required to ensure their timely germination (45).

To facilitate spore germination, we compared the effects of two germinants (l-alanine and AGFK mixture) and their combination, observing the cell behavior (Fig. 8A) and phage abundance in the medium (Fig. 8B). Based on the observed decrease of optical density at 600 nm (OD600) during spore germination, the germination time was estimated to be 30 to 35 min when induced with 20 mM l-alanine or 20 mM AGFK mixture. Faster germination was induced by the combination of 10 mM l-alanine and 10 mM AGFK mixture. Once phages are incorporated into endospores, the time allowed for phage release should consider not only the endospore germination and outgrowth time but also the phage latent period in vegetative cells. PBSC1 normally has a latent time of 35 min, but, when entrapped, produces only very low titers during the first 150 min of germination. However, when l-alanine or AGFK mixture is added, phage release is observed earlier, after 90 to 120 min. We also observed that latent periods were reduced to around 60 min when cultures were amended simultaneously with both l-alanine and AGFK. In B. subtilis spores, the GerA receptor responds to l-alanine, while the AGFK mixture works on the receptors GerB and GerK to trigger germination (17). Consistent with previous work, germinant combinations can be more effective than when applied individually (46, 47). Thus, spores not only integrate but can also amplify signals from multiple germinants, and multiple GRs accelerate overall spore germination.

FIG 8.

FIG 8

Germination induction of Bacillus spores and release of entrapped phage PBSC1. (A) B. subtilis germination triggered by different germinants was monitored by changes in optical density (initial OD600 = 0.8). (B) Release of entrapped PBSC1 under different inducing conditions. The germinant concentrations were 20 mM for l-alanine, 20 mM (each) l-asparagine, d-glucose, d-fructose, and K+ (AGFK), or 10 mM l-alanine + 10 mM each AGFK component for the combined treatment.

Practical implications and challenges.

Phages have demonstrated strong potential to combat antibiotic-resistant bacteria through multiple modes of action (e.g., selective microbial control [48], biofilm dispersal [49], and antibiotic resistance resensitization [50]). The effectiveness of phage treatment depends not only on specific phage-host interactions, but also on the conservation of phage viability during delivery. In the pseudolysogenic state, the genomes of phages infecting sporulating bacteria get entrapped in the mature spores and are consequently protected from harsh environmental stressors. Our results show that spores can be harnessed to serve as cost-effective, resilient storage and delivery vehicles for phages capable of infecting spore-forming bacteria (Fig. 1). Furthermore, polyvalent phages enable the use of a benign surrogate host (e.g., B. subtilis) and eliminate the need to separate phages from pathogenic hosts prior to encapsulation (7, 51), which could substantially decrease production cost (52).

This approach could be used to control the growth of spore-forming pathogens. such as Bacillus anthracis and B. cereus strains causing gastrointestinal diseases (53). For example, polyvalent phage genomes entrapped in B. subtilis spores could be seeded in areas containing B. anthracis or B. cereus spores. Thus, when conditions become suitable for germination, the phages would continue their lytic cycle and subsequently infect these potential pathogens. Spore-entrapped phage genomes could also be considered for gut microbiome manipulations, as they would resist the low pH of the stomach during transit. In such scenarios, spore germination and outgrowth could be triggered by gut nutrients.

While the use of spore-phage system opens up new potential microbial control applications for environmental and public health protection, some challenges should be considered. For example, this approach is dependent on polyvalent phages infecting both endospore formers and targeted bacteria. Thus, the availability of such phages may limit the scope of some applications. Nevertheless, recent studies have shown that polyvalent phages may be more widespread than previously recognized (24, 25), and modification of phage isolation methods could facilitate their enrichment (26).

Conclusions.

Overall, this study demonstrates phage applicability for controlling pathogenic endospore formers (e.g., Clostridium spp.) and a new method for phage protection during delivery, as well as during long-term, room-temperature storage. Using bacterial endospores as carriers and protection shells for polyvalent phage genomes holds promise for broadening the scope and efficacy of phage biocontrol. Nevertheless, further research with more realistic settings is needed to enhance safe and practical applications, including enhancing the phage genome entrapment efficiency, improving phage release, and optimizing phage dosage and application frequency in microbial control.

MATERIALS AND METHODS

Bacterial strains and culture conditions.

The bacterial strains used in this study were Bacillus subtilis subsp. subtilis (ATCC 6051) and Bacillus cereus NRS 248 (ATCC 10987). Tryptic soy broth (TSB) medium was used for bacterial culture and phage characterization in terms of growth parameters. B. subtilis sporulation and phage incorporation were carried in medium 121B, containing basal medium 121 (0.08 M NaCl, 0.02 M KCl, 0.02 M NH4Cl, 0.12 M Tris, 1 mM MgCl2, 0.2 mM CaCl2, 0.002 mM FeCl3, 2.5 mM Na2SO4, and 0.002 mM ZnCl2; pH adjusted to 7.5 with HCl) supplemented to final concentrations of 0.2% glucose, 0.2% Casamino Acids, 2.5 mM K2HPO4, 0.8 mM MnCl2, 3.4 mM sodium citrate, and 0.15 mM FeCl3 (21). All bacterial incubations, sporulation, and germination were performed at 37°C.

The double-layer plaque assay used tryptone base-layer agar and tryptone soft agar (26). The numbers of mature spores and phages were enumerated by colony and plaque counting assays, respectively. Bacteriophages were stored at 4°C in SM buffer (50 mM Tris-HCl [pH 7.5], 0.1 mM NaCl, 8 mM MgSO4, and 0.01% gelatin). The endospores of B. subtilis were kept in ultrapure water at 4°C.

Polyvalent phage isolation and characterization.

A heterogeneous phage stock was obtained using fertile soil samples from the Rice University campus (29.7174° N, 95.4018° W). A sequential multiple-host isolation approach (26) was applied for polyvalent phage isolation, with the host sequence B. subtilis followed by B. cereus followed by B. subtilis again. A single clear phage plaque was harvested from the last plate's bacterial lawn and diluted in SM buffer. The phage was further purified on B. subtilis culture three times to remove any contaminant phages according to standard procedures. The isolated phages were characterized in terms of host range, efficiency of plating (EOP), adsorption rate constant, latent time, and burst size, as previously described (26). In adsorption tests, the fraction of free phages was measured by plaque counts as function of time, and first-order phage adsorption rate constants were determined as the linear regression slope of ln(phage concentration) versus time. The latent time and burst size were determined by the phage one-step growth curves (54). The morphology of isolated phages was determined via a JEOL 2010 transmission electron microscope (TEM) (JEOL USA, MA) after negative staining with 2% uranyl acetate (55).

Sporulation and phage genome entrapment.

After overnight incubation in Trypticase soy broth (TSB), B. subtilis culture was synchronized for sporulation in medium 121/121B as previously described (21). Briefly, the B. subtilis culture was washed with medium 121, resuspended in medium 121B, and grown in medium 121B until it reached the early stationary phase. After centrifugation, bacteria were harvested and then incubated for sporulation in 121B medium, with shaking at 160 rpm. Phase-contrast images of sporulating B. subtilis were obtained by microscopy (DM6000B; Leica). At different times after incubation, sporulating cells were mixed with phage for 15 min at MOIs of 0.1, 1, and 10. The free phages were removed by centrifugation (five times) and the pellet was resuspended in 121B medium (without glucose or Casamino Acids) for spore maturation. The spores were harvested after 24 h or 48 h maturation and then purified as previously reported (56). Briefly, suspensions were treated with 50 mM Tris-HCl (pH 7.2) containing 50 μg/ml of lysozyme for 1 h at 37°C to inactivate vegetative cells, and then the spores were released by vortexing in 0.05% SDS solution. Heat treatment (70°C for 30 min) was applied to inactivated free cells or vegetative cells. Samples were further washed three times with ultrapure water to remove cell debris and extracellular phages. The morphology and purity of spores were observed by JEOL 6500 scanning electron microscopy (SEM) (JEOL USA, MA) after fixation with glutaraldehyde and dehydration with ethanol (57).

Efficiency of phage genome entrapment.

The spore suspensions were spread on nutrient agar for enumeration of uninfected spores and embedded in the soft agar of double-layer plates for entrapped phage quantification. The number of surviving colonies was used to represent the number of uninfected spores, while that of plaques in soft agar represented the number of spores containing phage genomes. The efficiency of phage entrapment was calculated as follows (23):

F=100×P/(P+S) (1)

where F is the fraction of spores producing infective centers (%), P is the number of infective centers from infected spores (COI/ml), S is the number of surviving colonies from uninfected spores (CFU/ml), and (P + S) is the total number of infected and uninfected spores.

Spore germination and phage release tests.

After heat activation in water at 70°C for 30 min and then cooling on ice, spore germination was carried out in 25 mM Tris-HCl buffer (pH 7.4) supplemented with germinants of interest, as follows: (i) 20 mM l-alanine, (ii) 20 mM each l-asparagine, d-glucose, d-fructose, and K+ (termed AGFK), and (iii) 10 mM l-alanine + 10 mM each AGFK. The initial optical density of spore suspension was 0.8 OD600, and the decrease in OD600 in germinating cultures was monitored by plate reader (Molecular Devices, MA). The relative OD600 was calculated by division of each reading (At) by the initial reading (A0). To determine the latent time for phage in spores and the pattern of phage release, samples were collected at 30-min intervals and immediately subjected to a double-layer plate assay for phage enumeration.

Resistance tests for free phages and endospore-protected phage genomes.

Free phage and endospore-protected phage genome stability were tested with exposure to several environmental stressors, as follows. The initial phage concentration was approximately 105 PFU/ml. Wet heat resistance was tested in a water bath for 15 min at temperatures ranging from 30 to 80°C. Samples were cooled to room temperature before submission to double-layer plaque assay. Phage pH resistance was assessed by adding the samples into solutions of various pHs from 2 to 13 for 1 h. The pH was neutralized before phage enumeration. Free phages and protected phages were also subjected to Cu2+ resistance assays. Samples were incubated for 1 h in CuSO4 solutions with Cu2+ concentrations of 0.1, 0.5, 1.0, 5.0, and 10 mg/liter. The air-dried endospores containing phage genomes were stored in the dark at room temperature to test the long-term stability of endospore-protected phage genomes.

Statistical analysis.

The Poisson distribution was used to describe the distribution of infected cells. The Poisson probability function was used to calculate the fraction of uninfected bacteria (i.e., P(0) = 1 − e−MOI) (58), where MOI is the multiplicity of infection, defined as phages used for infection per number of cells. The Student t test (two-tailed) was used to determine the significance of the differences between treatments. Differences were considered to be significant at the 95% confidence level (P < 0.05).

Supplementary Material

Supplemental file 1
zam018188743s1.pdf (573.3KB, pdf)

ACKNOWLEDGMENTS

This study was supported by an NSF PIRE grant (fund OISE-1545756). N.G. received financial support from the National Council for Scientific and Technological Development—Brazil.

Footnotes

Supplemental material for this article may be found at https://doi.org/10.1128/AEM.01186-18.

REFERENCES

  • 1.Nobrega FL, Costa AR, Kluskens LD, Azeredo J. 2015. Revisiting phage therapy: new applications for old resources. Trends Microbiol 23:185–191. doi: 10.1016/j.tim.2015.01.006. [DOI] [PubMed] [Google Scholar]
  • 2.Li L-L, Yu P, Wang X, Yu S-S, Mathieu J, Yu H-Q, Alvarez PJJ. 2017. Enhanced biofilm penetration for microbial control by polyvalent phages conjugated with magnetic colloidal nanoparticle clusters (CNCs). Environ Sci Nano 4:1817–1826. doi: 10.1039/C7EN00414A. [DOI] [Google Scholar]
  • 3.Salmond GPC, Fineran PC. 2015. A century of the phage: past, present and future. Nat Rev Microbiol 13:777. doi: 10.1038/nrmicro3564. [DOI] [PubMed] [Google Scholar]
  • 4.Ahiwale S, Koparde P, Deore P, Gunale V, Kapadnis BP. 2012. Bacteriophage based technology for disinfection of different water systems, p 289–313, T. Bhavdish S, Johri N, Prakash A (ed), Microorganisms in environmental management. Springer, Dordrecht, the Netherlands. [Google Scholar]
  • 5.Gross M. 2014. Phage therapies for plants and people. Curr Biol 24:R541–R544. doi: 10.1016/j.cub.2014.05.064. [DOI] [PubMed] [Google Scholar]
  • 6.Kazi M, Annapure US. 2016. Bacteriophage biocontrol of foodborne pathogens. J Food Sci Technol 53:1355–1362. doi: 10.1007/s13197-015-1996-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Yu P, Mathieu J, Lu GW, Gabiatti N, Alvarez PJ. 2017. Control of antibiotic-resistant bacteria in activated sludge using polyvalent phages in conjunction with a production host. Environ Sci Technol Lett 4:137–142. doi: 10.1021/acs.estlett.7b00045. [DOI] [Google Scholar]
  • 8.Ly-Chatain MH. 2014. The factors affecting effectiveness of treatment in phages therapy. Front Microbiol 5:51. doi: 10.3389/fmicb.2014.00051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Jończyk E, Kłak M, Międzybrodzki R, Górski A. 2011. The influence of external factors on bacteriophages—review. Folia Microbiol (Praha) 56:191–200. doi: 10.1007/s12223-011-0039-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Li J, Dennehy JJ. 2011. Differential bacteriophage mortality on exposure to copper. Appl Environ Microbiol 77:6878–6883. doi: 10.1128/AEM.05661-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Chaudhry RM, Nelson KL, Drewes JE. 2015. Mechanisms of pathogenic virus removal in a full-scale membrane bioreactor. Environ Sci Technol 49:2815–2822. doi: 10.1021/es505332n. [DOI] [PubMed] [Google Scholar]
  • 12.Xagoraraki I, Yin Z, Svambayev Z. 2014. Fate of viruses in water systems. J Environ Eng. 140:04014020. doi: 10.1061/(ASCE)EE.1943-7870.0000827. [DOI] [Google Scholar]
  • 13.Choińska-Pulit A, Mituła P, Śliwka P, Lába W, Skaradzińska A. 2015. Bacteriophage encapsulation: trends and potential applications. Trends Food Sci Technol 45:212–221. doi: 10.1016/j.tifs.2015.07.001. [DOI] [Google Scholar]
  • 14.Colom J, Cano-Sarabia M, Otero J, Aríñez-Soriano J, Cortés P, Maspoch D, Llagostera M. 2017. Microencapsulation with alginate/CaCO(3): A strategy for improved phage therapy. Sci Rep 7:41441. doi: 10.1038/srep41441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Ma Y, Pacan JC, Wang Q, Sabour PM, Huang X, Xu Y. 2012. Enhanced alginate microspheres as means of oral delivery of bacteriophage for reducing Staphylococcus aureus intestinal carriage. Food Hydrocoll 26:434–440. doi: 10.1016/j.foodhyd.2010.11.017. [DOI] [Google Scholar]
  • 16.Nicholson WL, Munakata N, Horneck G, Melosh HJ, Setlow P. 2000. Resistance of Bacillus endospores to extreme terrestrial and extraterrestrial environments. Microbiol Mol Biol Rev 64:548–572. doi: 10.1128/MMBR.64.3.548-572.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Setlow P. 2014. Germination of spores of Bacillus species: what we know and do not know. J Bacteriol 196:1297–1305. doi: 10.1128/JB.01455-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Sonenshein AL. 2006. Bacteriophages: how bacterial spores capture and protect phage DNA. Curr Biol 16:R14–R16. doi: 10.1016/j.cub.2005.12.007. [DOI] [PubMed] [Google Scholar]
  • 19.Łoœ M, Węgrzyn G. 2012. Pseudolysogeny, p 339–349. In Łobocka M, Szybalski WT (ed), Advances in virus research: bacteriophages, part A, vol 82 Academic Press, London, UK. [Google Scholar]
  • 20.Feiner R, Argov T, Rabinovich L, Sigal N, Borovok I, Herskovits A. 2015. A new perspective on lysogeny: Prophages as active regulatory switches of bacteria. Nat Rev Microbiol 13:641–650. doi: 10.1038/nrmicro3527. [DOI] [PubMed] [Google Scholar]
  • 21.Sonenshein AL, Roscoe DH. 1969. The course of phage phi-e infection in sporulating cells of Bacillus subtilis strain 3610. Virol J 39:265–276. doi: 10.1016/0042-6822(69)90047-6. [DOI] [PubMed] [Google Scholar]
  • 22.Kawamura F, Ito J. 1974. Bacteriophage gene expression in sporulating cells of Bacillus subtilis 168. Virology 62:414–425. doi: 10.1016/0042-6822(74)90403-6. [DOI] [PubMed] [Google Scholar]
  • 23.Meijer WJ, Castilla-Llorente V, Villar L, Murray H, Errington J, Salas M. 2005. Molecular basis for the exploitation of spore formation as survival mechanism by virulent phage ϕ29. EMBO J 24:3647–3657. doi: 10.1038/sj.emboj.7600826. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Malki K, Kula A, Bruder K, Sible E, Hatzopoulos T, Steidel S, Watkins SC, Putonti C. 2015. Bacteriophages isolated from Lake Michigan demonstrate broad host-range across several bacterial phyla. Virol J 12:164. doi: 10.1186/s12985-015-0395-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Doron S, Fedida A, Hernández-Prieto MA, Sabehi G, Karunker I, Stazic D, Feingersch R, Steglich C, Futschik M, Lindell D, Sorek R. 2016. Transcriptome dynamics of a broad host-range cyanophage and its hosts. ISME J 10:1437. doi: 10.1038/ismej.2015.210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Yu P, Mathieu J, Li M, Dai Z, Alvarez PJJ. 2016. Isolation of polyvalent bacteriophages by sequential multiple-host approaches. Appl Environ Microbiol 82:808–815. doi: 10.1128/AEM.02382-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Yosef I, Goren MG, Globus R, Molshanski-Mor S, Qimron U. 2017. Extending the host range of bacteriophage particles for DNA transduction. Mol Cell 66:721–728.e3. doi: 10.1016/j.molcel.2017.04.025. [DOI] [PubMed] [Google Scholar]
  • 28.Ando H, Lemire S, Pires Diana P, Lu Timothy K. 2015. Engineering modular viral scaffolds for targeted bacterial population editing. Cell Syst 1:187–196. doi: 10.1016/j.cels.2015.08.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Aizawa S-I. 2014. The flagellar world: electron microscopic images of bacterial flagella and related surface structures. Academic Press, Oxford, UK. [Google Scholar]
  • 30.Tewari A, Abdullah S. 2015. Bacillus cereus food poisoning: international and Indian perspective. J Food Sci Technol 52:2500–2511. doi: 10.1007/s13197-014-1344-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Traxler MF, Kolter R. 2015. Natural products in soil microbe interactions and evolution. Nat Prod Rep 32:956–970. doi: 10.1039/C5NP00013K. [DOI] [PubMed] [Google Scholar]
  • 32.Oechslin F, Piccardi P, Mancini S, Gabard J, Moreillon P, Entenza JM, Resch G, Que YA. 2017. Synergistic interaction between phage therapy and antibiotics clears Pseudomonas aeruginosa infection in endocarditis and reduces virulence. J Infect Dis 215:703–712. doi: 10.1093/infdis/jiw632. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Pires DP, Melo LDR, Vilas Boas D, Sillankorva S, Azeredo J. 2017. Phage therapy as an alternative or complementary strategy to prevent and control biofilm-related infections. Curr Opin Microbiol 39:48–56. doi: 10.1016/j.mib.2017.09.004. [DOI] [PubMed] [Google Scholar]
  • 34.Abedon ST, Thomas-Abedon C. 2010. Phage therapy pharmacology. Curr Pharm Biotechnol 11:28–47. doi: 10.2174/138920110790725410. [DOI] [PubMed] [Google Scholar]
  • 35.Riesenman PJ, Nicholson WL. 2000. Role of the spore coat layers in Bacillus subtilis spore resistance to hydrogen peroxide, artificial UV-C, UV-B, and solar UV radiation. Appl Environ Microbiol 66:620–626. doi: 10.1128/AEM.66.2.620-626.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Labrie SJ, Samson JE, Moineau S. 2010. Bacteriophage resistance mechanisms. Nat Rev Microbiol 8:317–327. doi: 10.1038/nrmicro2315. [DOI] [PubMed] [Google Scholar]
  • 37.Nicholson WL. 1990. Sporulation, germination and outgrowth, p 391–450. In Harwood CR, Cutting SM (ed), Molecular biological methods for Bacillus. John Wiley & Sons, Hoboken, NJ. [Google Scholar]
  • 38.Sanchez-Salas J-L, Setlow B, Zhang P, Li Y-Q, Setlow P. 2011. Maturation of released spores is necessary for acquisition of full spore heat resistance during Bacillus subtilis sporulation. Appl Environ Microbiol 77:6746–6754. doi: 10.1128/AEM.05031-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Berendsen EM, Boekhorst J, Kuipers OP, Wells-Bennik MHJ. 2016. A mobile genetic element profoundly increases heat resistance of bacterial spores. ISME J 10:2633. doi: 10.1038/ismej.2016.59. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Setlow P. 2014. Spore resistance properties. Microbiol Spectr 2. doi: 10.1128/microbiolspec.TBS-0003-2012. [DOI] [PubMed] [Google Scholar]
  • 41.Pei R, Lamas-Samanamud GR. 2014. Inhibition of biofilm formation by T7 bacteriophages producing quorum-quenching enzymes. Appl Environ Microbiol 80:5340–5348. doi: 10.1128/AEM.01434-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Paredes-Sabja D, Setlow P, Sarker MR. 2011. Germination of spores of Bacillales and Clostridiales species: mechanisms and proteins involved. Trends Microbiol 19:85–94. doi: 10.1016/j.tim.2010.10.004. [DOI] [PubMed] [Google Scholar]
  • 43.Luu S, Cruz-Mora J, Setlow B, Feeherry FE, Doona CJ, Setlow P. 2015. The effects of heat activation on Bacillus spore germination, with nutrients or under high pressure, with or without various germination proteins. Appl Environ Microbiol 81:2927–2938. doi: 10.1128/AEM.00193-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Nagler K, Setlow P, Li Y-Q, Moeller R. 2014. High salinity alters the germination behavior of Bacillus subtilis spores with nutrient and nonnutrient germinants. Appl Environ Microbiol 80:1314–1321. doi: 10.1128/AEM.03293-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Ghosh S, Setlow P. 2009. Isolation and characterization of superdormant spores of Bacillus species. J Bacteriol 191:1787–1797. doi: 10.1128/JB.01668-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Barlass PJ, Houston CW, Clements MO, Moir A. 2002. Germination of Bacillus cereus spores in response to l-alanine and to inosine: the roles of gerL and gerQ operonsc. Microbiology 148:2089–2095. doi: 10.1099/00221287-148-7-2089. [DOI] [PubMed] [Google Scholar]
  • 47.Atluri S, Ragkousi K, Cortezzo DE, Setlow P. 2006. Cooperativity between different nutrient receptors in germination of spores of Bacillus subtilis and reduction of this cooperativity by alterations in the GerB receptor. J Bacteriol 188:28–36. doi: 10.1128/JB.188.1.28-36.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Viertel TM, Ritter K, Horz H-P. 2014. Viruses versus bacteria—novel approaches to phage therapy as a tool against multidrug-resistant pathogens. J Antimicrob Chemother 69:2326–2336. doi: 10.1093/jac/dku173. [DOI] [PubMed] [Google Scholar]
  • 49.Bhattacharjee AS, Choi J, Motlagh AM, Mukherji ST, Goel R. 2015. Bacteriophage therapy for membrane biofouling in membrane bioreactors and antibiotic-resistant bacterial biofilms. Biotechnol Bioeng 112:1644–1654. doi: 10.1002/bit.25574. [DOI] [PubMed] [Google Scholar]
  • 50.Yosef I, Manor M, Kiro R, Qimron U. 2015. Temperate and lytic bacteriophages programmed to sensitize and kill antibiotic-resistant bacteria. Proc Natl Acad Sci U S A 112:7267–7272. doi: 10.1073/pnas.1500107112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Santos SB, Fernandes E, Carvalho CM, Sillankorva S, Krylov VN, Pleteneva EA, Shaburova OV, Nicolau A, Ferreira EC, Azeredo J. 2010. Selection and characterization of a multivalent Salmonella phage and its production in a nonpathogenic Escherichia coli strain. Appl Environ Microbiol 76:7338–7342. doi: 10.1128/AEM.00922-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Malik DJ, Sokolov IJ, Vinner GK, Mancuso F, Cinquerrui S, Vladisavljevic GT, Clokie MRJ, Garton NJ, Stapley AGF, Kirpichnikova A. 2017. Formulation, stabilisation and encapsulation of bacteriophage for phage therapy. Adv Colloid Interface Sci 249:100–133. doi: 10.1016/j.cis.2017.05.014. [DOI] [PubMed] [Google Scholar]
  • 53.Kotiranta A, Lounatmaa K, Haapasalo M. 2000. Epidemiology and pathogenesis of Bacillus cereus infections. Microbes Infect 2:189–198. doi: 10.1016/S1286-4579(00)00269-0. [DOI] [PubMed] [Google Scholar]
  • 54.Hyman P, Abedon ST. 2009. Practical methods for determining phage growth parameters, p 175–202. In Clokie MRJ, Kropinski AM (ed), Bacteriophages: methods and protocols, volume 1: isolation, characterization, and interactions. Humana Press, Totowa, NJ. [DOI] [PubMed] [Google Scholar]
  • 55.Ackermann H-W. 2012. Bacteriophage electron microscopy, p 1–32. In Łobocka M, Szybalski WT (ed), Advances in virus research: bacteriophages, part A, vol 82 Academic Press, London, UK. [Google Scholar]
  • 56.Tavares MB, Souza RD, Luiz WB, Cavalcante RCM, Casaroli C, Martins EG, Ferreira RCC, Ferreira LCS. 2013. Bacillus subtilis endospores at high purity and recovery yields: optimization of growth conditions and purification method. Curr Microbiol 66:279–285. doi: 10.1007/s00284-012-0269-2. [DOI] [PubMed] [Google Scholar]
  • 57.Yu P, Mathieu J, Yang Y, Alvarez PJJ. 2017. Suppression of enteric bacteria by bacteriophages: Importance of phage polyvalence in the presence of soil bacteria. Environ Sci Technol 51:5270–5278. doi: 10.1021/acs.est.7b00529. [DOI] [PubMed] [Google Scholar]
  • 58.Kasman LM, Kasman A, Westwater C, Dolan J, Schmidt MG, Norris JS. 2002. Overcoming the phage replication threshold: a mathematical model with implications for phage therapy. J Virol 76:5557–5564. doi: 10.1128/JVI.76.11.5557-5564.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental file 1
zam018188743s1.pdf (573.3KB, pdf)

Articles from Applied and Environmental Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES